RecruitingPhase 2NCT07381738
Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
Studying Epstein-Barr virus-associated malignant lymphoproliferative disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fudan University
- Principal Investigator
- Jiexian MaHuadong Hospital
- Intervention
- Umbilical cord blood transplantation as treatment of Epstein-Barr virus-associated lymphoproliferative diseases(procedure)
- Enrollment
- 80 target
- Eligibility
- 14-80 years · All sexes
- Timeline
- 2026 – 2028
Study locations (2)
- Huadong hospital, Fudan university, Shanghai, Shanghai Municipality, China
- Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Collaborators
Huashan Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07381738 on ClinicalTrials.govOther trials for Epstein-Barr virus-associated malignant lymphoproliferative disorder
Additional recruiting or active studies for the same condition.
See all trials for Epstein-Barr virus-associated malignant lymphoproliferative disorder →